Anne C. Jarry
Nantes, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
TAP1 deficiency reshapes tumor antigenicity and enables CD8 T cell targeting in colorectal cancer.
Journal: Molecular therapy. Oncology
Published: January 28, 2026
Differential impact of genetic deletion of TIGIT or PD-1 on melanoma-specific T-lymphocytes.
Journal: Oncoimmunology
Published: July 10, 2024
STING-ATF3/type I interferon crosstalk: A potential target to improve anti-tumour immunity in chemotherapy-treated urothelial carcinoma.
Journal: Clinical and translational medicine
Published: April 08, 2024
A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers.
Journal: Science (New York, N.Y.)
Published: June 08, 2023
Editorial: Crosstalk between innate and adaptive immunity in colorectal cancer: Implications for immunotherapy.
Journal: Frontiers in immunology
Published: December 21, 2022
IL-22BP production is heterogeneously distributed in Crohn's disease.
Journal: Frontiers in immunology
Published: September 01, 2022
Defining the Immune Checkpoint Landscape in Human Colorectal Cancer Highlights the Relevance of the TIGIT/CD155 Axis for Optimizing Immunotherapy.
Journal: Cancers
Published: August 04, 2022
Targeting NKG2A to boost anti-tumor CD8 T-cell responses in human colorectal cancer.
Journal: Oncoimmunology
Published: March 17, 2022
Anti-tumor efficacy of a combination therapy with PD-L1 targeted alpha therapy and adoptive cell transfer of PD-1 deficient melanoma-specific human T-lymphocytes.
Journal: Oncoimmunology
Published: July 09, 2021
Last Updated: 09/26/2026